sécurité (1) risque (1) gestion (1) intérêts (1) champ (1) évaluation (1) effet (1) maladie (1) maladie cardiovasculaire (1) procès (1) Vienne (1) Vienne (1) Treatment (1) Agonists (1) Inhibitors (1) Accounts (1) Specialists (1) Will (1) Trials (1) Spring (1) Risk (1) Relevance (1) Population (1) Patients (1) Non-insulin-dependent diabetes (1) Management (1) Life expectancy (1) Interest (1) Glucose (1) Evaluation (1)